Premium
Synergistic Cytotoxicity Of Shikonin‐Silver Nanoparticles As An Opportunity For Lung Cancer
Author(s) -
Fayez Hend,
ElMotaleb Mohamed Abd,
Selim Adli Abdullah
Publication year - 2020
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.3818
Subject(s) - chemistry , cytotoxicity , silver nanoparticle , mtt assay , a549 cell , apoptosis , cancer cell , cell culture , viability assay , human lung , pharmacology , nanotechnology , nanoparticle , biochemistry , cancer , in vitro , medicine , materials science , biology , genetics
The combined action of shikonin and silver nanoparticles (AgNPs) for apoptosis in human cancer cells has not been elucidated. Hence, we investigated the synergistic combinatorial effect of shikonin and AgNPs in human lung cancer cells. Shikonin was used as a reducing and capping agent for AgNPs synthesis as a green method avoiding the hazards of chemical methods. Radiolabeling of shikonin‐AgNPs with radioactive iodine forming [ 131 I]I‐Shikonin‐AgNPs was carried out to enable the intracellular tracking of NPs. The antitumor effect of a combined treatment (shikonin‐AgNPs) was evaluated using tissue culture assay. The 50% inhibitory concentration (IC 50 ) of SHK‐AgNPs on A549 cells after 24 hours determined by an MTT assay is 2.4 ± 0.11 μg/mL. As a deduction, this study revealed that the combination of shikonin and AgNPs treatment significantly inhibited cell viability and proliferation of A549 cells (human lung carcinoma cell line) with a great potential than the monotherapy.